Old West Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-108,211
Closed -$159K 68
2025
Q1
$159K Buy
108,211
+46,092
+74% +$110K 0.06% 59
2024
Q4
$275K Sell
62,119
-5,842
-9% -$23.7K 0.11% 50
2024
Q3
$280K Buy
67,961
+1,509
+2% +$8.11K 0.11% 53
2024
Q2
$433K Buy
66,452
+9,995
+18% +$70.7K 0.19% 47
2024
Q1
$492K Sell
56,457
-464
-0.8% -$5.63K 0.25% 43
2023
Q4
$651K Buy
56,921
+761
+1% +$7.53K 0.33% 31
2023
Q3
$541K Sell
56,160
-21,590
-28% -$212K 0.27% 32
2023
Q2
$827K Buy
77,750
+2,531
+3% +$27.2K 0.43% 29
2023
Q1
$791K Buy
75,219
+2,061
+3% +$23.1K 0.43% 29
2022
Q4
$906K Buy
73,158
+645
+0.9% +$7.32K 0.57% 28
2022
Q3
$751K Hold
72,513
0.53% 28
2022
Q2
$836K Buy
72,513
+389
+0.5% +$4.58K 0.58% 26
2022
Q1
$907K Sell
72,124
-462
-0.6% -$5.3K 0.49% 27
2021
Q4
$846K Hold
72,586
0.41% 33
2021
Q3
$947K Hold
72,586
0.25% 36
2021
Q2
$934K Buy
72,586
+2,243
+3% +$25.7K 0.19% 45
2021
Q1
$786K Buy
+70,343
New +$743K 0.16% 41

Other funds holding IRWD

Old West Investment Management's IRWD Position: Q2 2025 in Review

Old West Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 108,211 shares — an estimated $159K sold.

Old West Investment Management first reported a position in IRWD in Q1 2021 and held it in 17 quarters. The position peaked at $947K in Q3 2021. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Old West Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Old West Investment Management sold 108,211 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $159K.
  • Old West Investment Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 17 quarters.
  • Old West Investment Management's Ironwood Pharmaceuticals position peaked at $947K in Q3 2021.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Old West Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.